Canadian Cardiovascular Society and Elsevier Publish Issue of the Canadian Journal of Cardiology

By Elsevier, PRNE
Sunday, February 20, 2011

Issue Marks the Beginning of Their Partnership, Includes CCS Atrial Fibrillation Guidelines

PHILADELPHIA, Pennsylvania, February 21, 2011 - Elsevier and the Canadian Cardiovascular Society (CJC) announce the
publication of the January/February 2011 issue of the Canadian Journal of
Cardiology (CJC), the first in their partnership. This theme issue focused on
atrial fibrillation includes the long-awaited Canadian Cardiovascular Society
Atrial Fibrillation Guidelines.

The CCS Atrial Fibrillation Guidelines are notable for the novel grading
system adopted by the CCS. These guidelines address pathophysiology and
investigation, emergency management, anti-arrhythmic drug therapy, stroke
prevention, catheter ablation, prevention of postoperative atrial
fibrillation, and surgical procedures to control arrhythmia.

The selection of the atrial fibrillation theme reflects the intention of
Editor-in-Chief Stanley Nattel, MD, to focus on important clinical problems,
with particular emphasis on knowledge translation. "The term 'translational
research' is generally used for the translation of original basic research to
clinical application," says Dr. Nattel. "However, the concept of 'knowledge
translation' is much broader, including translation of clinical and
population science to clinical application, translation of novel clinical
insights and concerns into priorities in bench research, and translation of
guidelines into clinical practice, as well as the classical bench-to-bedside
meaning," he added.

First launched in 1985, the Canadian Journal of Cardiology began as a
controlled circulation journal. The Journal has matured to become the
official journal of the Canadian Cardiovascular Society (CCS) and is
recognized as the voice of the specialty in Canada.

About the Canadian Journal of Cardiology (CJC)

The Canadian Journal of Cardiology ( is the
official journal of the Canadian Cardiovascular Society (
It is a vehicle for the national and international dissemination of new
knowledge in cardiology and cardiovascular science, particularly serving as a
major venue for the results of Canadian cardiovascular research and Society
guidelines. The Journal publishes original reports of clinical and basic
research relevant to cardiovascular medicine as well as editorials, review
articles, case reports, and papers on health outcomes, policy research,
ethics, medical history, and political issues affecting practice.

About the Canadian Cardiovascular Society (CCS)

The Canadian Cardiovascular Society is the professional association for
Canadian cardiovascular physicians and scientists working to promote
cardiovascular health and care through knowledge translation, professional
development, and leadership in health policy. The CCS provides programs and
services to its 1900+ members and others in the cardiovascular community,
including guidelines for cardiovascular care, the annual Canadian
Cardiovascular Congress, and, with the Canadian Cardiovascular Academy,
programs for trainees. More information about the CCS and its activities can
be found at

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet ( and Cell
(, and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (, SciVerse Scopus
(, Reaxys (, MD Consult
( and Nursing Consult (, which enhance the productivity of science
and health professionals, and the SciVal suite ( and
MEDai's Pinpoint Review (, which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (, a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact
    Francesca Costanzo

Media Contact: Francesca Costanzo, +1-215-239-3249, F.Costanzo at

Health Care / Hospitals News

Elsevier News

will not be displayed